Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Mar 18.
Published in final edited form as: J Org Chem. 2011 Feb 4;76(6):1883–1886. doi: 10.1021/jo102294j

Chiral Epoxides via Borane Reduction of 2-Haloketones Catalyzed By Spiroborate Ester: Application to the Synthesis of Optically Pure 1,2-Hydroxy Ethers and 1,2-Azido Alcohols

Kun Huang 1, Haiyang Wang 1, Viatcheslav Stepanenko 1, Melvin De Jesús 1, Carilyn Torruellas 1, Wildeliz Correa 1, Margarita Ortiz-Marciales 1,*
PMCID: PMC3055923  NIHMSID: NIHMS272064  PMID: 21294519

Abstract

graphic file with name nihms272064f3.jpg

An enantioselective borane-mediated reduction of a variety of 2-haloketones using 10% of spiroaminoborate ester 1 as catalyst is described. By a simple basic workup of 2-halohydrins, optically active epoxides are obtained in high yield and with excellent enantiopurity (up to 99% ee). Ring opening of oxiranes with phenoxides or sodium azide is investigated under different reaction conditions affording nonracemic 1,2-hydroxy ethers and 1,2-azido alcohols with excellent enantioselectivity (99% ee) and in good to high chemical yield.


Nonracemic epoxides are not only recognized for their biological importance,1 but also as key intermediates in diverse chemical transformations for the synthesis of chiral auxiliaries, natural products and chiral drugs.2,3 Moreover, chiral epoxides have been recently used as catalysts for asymmetric induction in the auto-catalyzed organozinc addition to an aldehyde.4 Consequently, in the last thirty years, a variety of direct epoxidation and resolution methods for the synthesis of enantiopure oxiranes have been successfully developed.58 More convenient and efficient routes to prepare optical pure styrene oxides involve the initial enzymatic9 or chemical asymmetric reduction of α-halogenated acetophenones.1012 Asymmetric transfer hydrogenation of 2-chloroacetophenones has been recently applied using Rh, Ru or Ir diamino complexes as chiral catalysts. Environmentally friendly boron reagents have been used for the reduction of a variety of α-haloketones and the halohydrins are easily converted to nonracemic epoxides without racemization.11,12 These methods can be considered, essentially, as a “one pot” procedures valuable for substrates with sensitive groups due to the very mild reaction conditions. Lithium and sodium borohydride reduction of α-haloacetophenones with an stoichiometric amount of (L)-TarB-NO2, prepared from tartaric acid and m-nitrophenylboronic acid, was employed recently to afford styrene oxides in moderate to high enantiopurity.11a The most recognized chiral catalysts for the enantioselective borane–mediated reduction of unsymmetrical ketones with outstanding and predictable stereoselectivities are 1,3,2-oxazaborolidines (OAB) derived from nonracemic 1,2-amino alcohols.12 These remarkable reagents were initially discovered by Itsuno and further developed and studied by Corey and others.12 The in situ prepared B-H oxazaborolidine derived from diphenylprolinol was first proposed and used by Corey’s group in the borane reduction of α-chloroacetophenone in THF affording the (S)-chlorohydrin in high yield and excellent enantiomeric excess.12b Nevertheless, the in situ prepared B-H oxazaborolidines are known to form side-products diminishing in some cases the effectiveness of the catalyst.13

A series of stable crystalline aminoborate esters, derived from a variety of nonracemic 1,2-amino alcohols, ethylene glycol and inexpensive triisopropyl borate, were previously reported by our group.14,15 The most effective and convenient aminoborate complexes used as catalyst for the borane-mediated reduction of ketones 14,15a–g and benzyl oximes15h are shown in Fig. 1.

FIGURE 1.

FIGURE 1

Representative Aminoborate Complexes.

Spiroaminoborate ester 1 derived from diphenylprolinol was highly effective for the reduction of a variety of aryl,15a–d heteroaryl,15e, α-alkoxy15f and aliphatic15g ketones providing the desired secondary alcohols in excellent yield with excellent enantioselectivity, higher or similar to Corey’s OAB (CBS reagent). Presently, we are interested in the synthesis of nonracemic α-aryloxy- and α-amino alcohols as important chiral building blocks for the preparation of neurobiological active molecules. We, herein, describe a simple and convenient procedure for the preparation of optical active epoxides in high yield with excellent enantiopurity and their application to the synthesis of optically pure β-hydroxy ethers and 1,2-azido alcohols.

To develop a suitable procedure for the synthesis of epoxides, the asymmetric reduction of α-chloroacetophenone was initially carried out using 10% catalyst 1 and 0.7 equiv BH3•DMS in THF at room temperature, followed by treatment of the crude chlorohydrin with 2 N NaOH. The styrene oxide was afforded in good yield and without racemization. To optimize the reaction conditions, α-Cl and α-Br acetophenone were reduced under different catalytic loads and borane sources, and subsequently, the crude halohydrins were cyclized under basic conditions. Since BH3•DMS provides similar enantioselectivity as BH3•THF, we consider its use more attractive for a convenient method due to its low price and stability. In addition, the reduction of α-Br acetophenone afforded the corresponding epoxide in higher enantiopurity than the chloro analogue, providing 99% ee, and good chemical yield with 10% of catalyst 1, 0.7 equiv BH3•DMS in THF at room temperature for 0.5 h.

Encouraged by the remarkable enantioselectivity obtained in the synthesis of the styrene oxide using spiroaminoborate 1, we explored its scope in the reduction of a variety of aromatic and aliphatic α-halogenated ketones and their halohydrins conversion to enantioenriched oxiranes. As indicated in Table 1, α-haloacetophenones with Me, MeO, Cl, F, CN and NO2 ring-substituents (entries 1–10) were reduced to the S-2-bromo-1-phenylethanols, which were transformed under basic conditions to the S-epoxides in good to excellent yields and outstanding enantioselectivities (97 – 99% ee). The presence of different substituents on the aromatic ring has no significant effect on the ee values (entries 2–10). However, the cyclization of 2-bromo-4-methylphenyl-1-ethanol (entry 9) by treatment with 2 N NaOH afforded the corresponding epoxide in lower yield. However, the use of t-BuOK led us to the expected epoxide in good yield. In addition, the α-bromocyclohexyl ethanone and α-bromo adamanty ethanone afforded the epoxides in high yield and excellent enantiomeric excess (entries 11–12). The absolute configuration of the oxiranes was determined by comparing the optical rotation with the literature values.8,10,11a,15f,16a Racemic β-hydroxy ethers were prepared as standards for HPLC analysis by the sodium borohydride reduction of β-phenoxyketones (8).

TABLE 1.

Asymmetric Reduction α-Haloketones for the Synthesis of Epoxidesa

graphic file with name nihms272064t1.jpg

entry epoxides yield
(%)b
ee
(%)c
1 graphic file with name nihms272064t2.jpg 7a 90 99
2 graphic file with name nihms272064t3.jpg 7b 90 99
3 graphic file with name nihms272064t4.jpg 7c 66 98
4 graphic file with name nihms272064t5.jpg 7d 89 99
5 graphic file with name nihms272064t6.jpg 7e 95 97
6 graphic file with name nihms272064t7.jpg 7f 78 95
7 graphic file with name nihms272064t8.jpg 7g 91 99
8 graphic file with name nihms272064t9.jpg 7h 76 99d
9 graphic file with name nihms272064t10.jpg 7i 71e 98d
10 graphic file with name nihms272064t11.jpg 7j 72 98f
11 graphic file with name nihms272064t12.jpg 7k 88 97d
12 graphic file with name nihms272064t13.jpg 7l 93 >99d
a

All the reactions were performed as reported in the experimental procedure.

b

Purified by flash chromatography or Kugelrohr distillation.

c

Determined by GC on a chiral column.

d

Determined by chiral HPLC on the basis of β-hydroxyl ether.

e

t-BuOK was used in the epoxidation reaction.

f

Determined by chiral HPLC.

Regioselective ring opening of oxiranes with nucleophiles is an important route to obtain a broad range of nonracemic 1,2-substituted alcohols as intermediates for the synthesis of key pharmaceutical compounds, as well as chiral catalysts.3,1719 Optically active β-hydroxy ethers are valuable synthetic intermediates in a wide variety of potentially bioactive compounds.2g,17a Although, asymmetric syntheses of terminal epoxides in high optical purity are well established,58 efficient methods for the synthesis of nonracemic β-aryloxy alcohols via epoxide ring-opening remains limited.18 Moreover, synthesis of 2-aryloxy-1-phenylethanols by kinetic resolution of styrene oxide with phenol in the presence of (salen)Co(OAc) in tert-butyl ether resulted in a mixture of regioisomers in a 2:1 ratio, although the products were not identified.16b Thus, we were interested in studying the regioselective ring-opening of enantiopure epoxides with phenols or phenoxides. Initially, the ring-opening of racemic 2-phenyloxirane was studied using sodium phenoxide in the presence of β-cyclodextrin in water at 60 °C.18c However, the major product was, 2-phenoxy-2-phenylethanol (9a), produced by ring opening at the benzylic position contrary to the reported 2-aryloxy-1-phenylethanol (10a). The compound 9a was identified by 1H NMR analysis and compared with a standard sample of 10a prepared according to previous reported procedure.15f Further analyses of the reaction mixture by 1H NMR showed 9a, 10a and diol 11 in 100/8/88 ratio, and in 46%, 6% and 38% isolated yield, respectively. For comparison purposes, other substrates were also reinvestigated. See Supporting Information.

The low regioselectivity and poor yields in the previous methods led us to search an alternative route for the synthesis of the desired (S)-1,2-aryoxy ethanols 10. After various optimization studies with different bases (K2CO3, NaOH, KOH and NaH) and solvents (CH3CN, THF and DMF), in addition to various temperatures and reaction times, it was found that the treatment of epoxides 7 with phenol, previously treated with NaH, in anhydrous DMF at 60 °C for 36 h, provided the desired (S)-β-hydroxy ethers 10 in good yield without racemization. As indicated in Table 2, representative aromatic and aliphatic of (S)-β-hydroxy ether were produced under the selected conditions with outstanding enantiopurity (97 to >99% ee) and in moderate to good isolated yields of pure products (entries 1–6).

TABLE 2.

Preparation of β-Hydroxy Ethers 10 from Epoxides 7

graphic file with name nihms272064t14.jpg

entry product yield
(%)a
ee
(%)b
1 graphic file with name nihms272064t15.jpg 10a 77 >99
2 graphic file with name nihms272064t16.jpg 10h 62 99
3 graphic file with name nihms272064t17.jpg 10i 88 98
4 graphic file with name nihms272064t18.jpg 10j 82 98
5 graphic file with name nihms272064t19.jpg 10k 52 97
6 graphic file with name nihms272064t20.jpg 10l 77c >99
a

The products were obtained by preparative TLC.

b

Determined by HPLC (Chiralcel OD-H).

c

Reaction time 36 h.

Optically active 2-azido-2-aryl ethanols are well-known precursor for the synthesis of a broad variety of enantiopure 1,2-amino alcohols, which are essential building blocks in the preparation of neurobiological active compounds.3,17 In addition, β-amino alcohols have been extensively used in asymmetric synthesis as chiral ligands,3 organic catalysts18e,21 and chiral auxiliaries or transfer agents.22 Recently, Qu and coworkers20a reported the preparation of racemic 1,2-diols and 1,2-azido alcohols by the ring-opening of epoxides in hot water. Due to the importance of nonracemic 1,2-amino alcohol, we were interested in studying the ring opening reaction of optically pure epoxides with NaN3. As indicated in Scheme 1, when styrene epoxide (7a) and sodium azide were heated in water at 60 °C for 3.5 h, 2-azido-2-phenyl ethanol 12a was formed as the main product with only trace amount of regioisomer 13a, as determined by GC-MS and 1H NMR analyses of the crude product. The ratio of 12a and 13a by GC-MS analysis was 95.4:4.6. After purification by preparative TLC, it was afforded (S)-12a in 91% yield and 99% ee, based on HPLC analysis on a chiral column. Since highly enantiopure (S)-1-phenyl-2-azido ethanol was obtained, and more significantly, with complete inversion of configuration, the reaction was carried out with the p-chlorostyrene oxide 7d to demonstrate the generality of this valuable ring opening reaction. According to the analysis by GC-MS, the ratio of 2-azido-arylethanol 12d to 13d was 93:7. Remarkably, 12d was isolated in excellent yield (88%) and its optical purity was 98% ee. The stereochemistry of these compounds was confirmed by full spectroscopic analysis and optical rotation. Interestingly, this transformation only slightly decreased the enantioselectivities of compounds 12a (99% ee) and 12d (98% ee), obtaining the 2-azido-1-arylethanols with inversion of configuration at the stereogenic center. Noteworthy, this highly regioselective and enantioselective conversion of styrene oxides to 1,2-azido alcohols was conducted under mild and environmental favorable conditions using only hot water, providing a rapid access to important non natural amino alcohols, as well as to biological building blocks that can be used for example in the click chemistry for the formation of chiral triazoles or amides.23 Further expansion of the azidolysis reaction of epoxides and reduction of the azido group to obtain a variety of 2-amino-2-heteroaryl ethanols will be addressed in future studies.

SCHEME 1.

SCHEME 1

Ring-opening of Epoxides with NaN3 in Hot Water

In summary, the enantioselective reduction of 2-haloketones using 10% of the spiroaminoborate ester 1 offers a convenient and facile route for the synthesis of a variety of highly enantiopure epoxides. The ring-opening of racemic styrene oxides by aryloxy nucleophiles in hot water in the presence of β-cyclodextrin takes place by a preferential nucleophilic attack to the benzylic position providing 2-aryloxy-2-aryl ethanols as the mayor product. However, the treatment of chiral epoxides, with PhONa in anhydrous DMF at 60 °C for 24–36 h, gives mainly 1-aryl and 1-alkyl β-aryloxy ethanols 10 in outstanding ee and good chemical yield. In addition, remarkable regioselective nucleophilic attack of NaN3 to (S)-epoxides in hot water takes place affording optically pure (R)-2-azido-2-aryl ethanols 13 with complete inversion of configuration in outstanding enantiopurity (up to 99% ee) and in high yield.

Experimental Section

General procedure for asymmetric reduction and epoxidation

To a solution of spiroaminoborate ester 115 (64 mg, 0.2 mmol) in dry THF (5 mL) was added BH3•DMS (0.14 mL, 10 M, 1.4 mmol) at room temperature under N2 atmosphere, and the solution was stirred for 30 min. A solution of the 2-haloketone (2 mmol) in dry THF (4 mL) was added dropwise for 1 h. After the addition was complete, the reaction mixture was stirred for 30 min, cooled at 0 °C, and quenched with MeOH (5 mL). The solvents were removed under reduced pressure, and the residue was treated with 2 N NaOH (5 mL) in THF (10 mL) for 2 h. After an aqueous work-up the residue was purified by flash column chromatography on silica.

Typical procedure for the preparation of enantiopure β-hydroxy ethers: (S)-(+)-1-(3-Methoxy-phenyl)-2-phenoxyethanol (10j)

A dried three-necked 25 mL round bottom flask charged with NaH (30.3 mg, 1.2 mmol, 1.2 equiv, 95%) in anhydrous DMF (2 mL) was added dropwise PhOH (94.1 mg, 1.0 mmol) in anhydrous DMF (2 mL) at ambient temperature under nitrogen. After the mixture was stirred for 10 min, a solution of epoxide 7j (150.2 mg, 1.0 mmol) in anhydrous DMF (2 mL) was added dropwise. The mixture was stirred at 60 °C for 24 h and after aqueous work-up the residue was purified by preparative TLC. The desired product was obtained in 82% yield (200 mg) as colorless oil; 98% ee, determined by chiral HPLC analysis.

General procedure for the preparation of 2-azido-2-arylethanols

To a stirred suspension of epoxide (1 mmol) in distilled water (6 mL) in a 25 mL flask with condenser was added sodium azide (2 mmol, 130 mg). The mixture was stirred for 3.5 h at 60 °C and then, 20 mL water was added. The product was isolated by preparative TLC.

Supplementary Material

1_si_001
2_si_002

Acknowledgment

Financial support by the National Institute of Health through their MBRS (GM 08216) and NIH-INBRE (NC P20 RR-016470) grants is greatly appreciated. The NIH-INBRE and NIH-RISE, NIH-MARC, NSF-AMP undergraduate student’s support is also gratefully acknowledged.

Footnotes

Supporting Information Available: Characterization data of all compounds. This material is available free of charge via the Internet at http://pubs.acs.org.

REFERENCES

  • 1.(a) Hatakeyama S, Ochi N, Takano S. Chem. Pharm. Bull. 1993;41:1358. [Google Scholar]; (b) Jerina DM, Daly JW. Science. 1974;185:573. doi: 10.1126/science.185.4151.573. [DOI] [PubMed] [Google Scholar]; (c) Rokach J, Young RN, Kakushima M, Lau C-K, Seguin R, Frenette R, Guindon Y. Tetrahedron Lett. 1981;22:979. [Google Scholar]
  • 2.(a) Hudlicky T, Tian X, Kı^nigsberger K, Rouden J. J. Org. Chem. 1994;59:4037. [Google Scholar]; (b) Satake A, Shimizu I, Yamamoto A. Synlett. 1995:64. [Google Scholar]; (c) Shao H, Zhu Q, Goodman M. J. Org. Chem. 1995;60:790. [Google Scholar]; (d) Schmidt B, Kunz O, Biernat A. J. Org. Chem. 2010;75:2389. doi: 10.1021/jo1002642. [DOI] [PubMed] [Google Scholar]
  • 3.For a review on the reactivity of epoxides: Bart¢k M, Lang KL. In: The Chemistry of Functional Groups, Supplement E. Patai S, editor. New York: Wiley; 1980. p. 609. Schneider C. Synthesis. 2006:3919.
  • 4.Kawasaki T, Shimizu M, Sato I, Soai K. Tetrahedron, Asymmetry. 2004;15:3699. [Google Scholar]
  • 5.(a) Sharpless Angew. Chem. Int. Ed. 2002;41:2024. [Google Scholar]; (b) Katsuki T, Sharpless KB. J. Am. Chem. Soc. 1980;102:5976. [Google Scholar]; (c) Zhang W, Basak A, Kosugi Y, Hoshino Y, Yamamoto H. Angew. Chem. Int. Ed. 2005;44:4389. doi: 10.1002/anie.200500938. [DOI] [PubMed] [Google Scholar]; (d) Zhang W, Yamamoto H. J. Am. Chem. Soc. 2007;129:286. doi: 10.1021/ja067495y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.(a) Brandes BD, Jacobsen NE. J. Org. Chem. 1994;59:4378. [Google Scholar]; (b) Katsuki T, Martin VS. Org. React. 1996;48:1–299. [Google Scholar]; (c) Jacobsen EN, Wu MH. In: Jacobsen EN, Pfaltz A, Yamamoto H, editors. Heidelberg: Springer-Verlag; 1999. p. 649. [Google Scholar]; (d) Jacobsen EN. In: Catalytic Asymmetric Synthesis. Ojima I, editor. VCH: New York; 1993. pp. 159–202. [Google Scholar]; (e) Jacobsen EN. Acc. Chem. Res. 2000;33:421. doi: 10.1021/ar960061v. [DOI] [PubMed] [Google Scholar]; (f) Matsumoto K, Oguma T, Katsuki T. Angew. Chem. Int. Ed. 2009;48:7432. doi: 10.1002/anie.200903567. [DOI] [PubMed] [Google Scholar]; (g) Schaus SE, Brandes BD, Larrow JF, Tokunaga M, Hansen KB, Gould AE, Furrow ME, Jacobsen EN. J. Am. Chem. Soc. 2002;124:1307. doi: 10.1021/ja016737l. [DOI] [PubMed] [Google Scholar]
  • 7.(a) Tu Y, Wang Z-X, Shi Y. J. Am. Chem. Soc. 1996;118:9806. [Google Scholar]; (b) Wang Z-X, Tu Y, Frohn M, Zhang J-X, Shi Y. J. Am. Chem. Soc. 1997;119:11224. [Google Scholar]; (c) Wang Z-X, Shi Y. J. Org. Chem. 1997;62:8622. doi: 10.1021/jo962392r. [DOI] [PubMed] [Google Scholar]; (d) Burke CP, Shi Y. J. Org. Chem. 2007;72:4093. doi: 10.1021/jo070205r. [DOI] [PubMed] [Google Scholar]; (e) Wong O, Shi Y. Chem. Rev. 2008;108:3958. doi: 10.1021/cr068367v. [DOI] [PubMed] [Google Scholar]
  • 8. Jin H, Li Z, Dong X. Org. Biomol. Chem. 2004;2:408. doi: 10.1039/b312469j. (b) Minireview: Finey NS. Chem. Biol. 1998;5:74. Pedragosa-Moreau S, Morisseau C, Zylber J, Archelas A, Baratti J, Furstoss R. J. Org. Chem. 1996;61:7402–7407. doi: 10.1021/jo960558i. Tokunaga M, Larrow JF, Kakiuchi F, Jacobsen EN. Science. 1997;277:936. doi: 10.1126/science.277.5328.936.
  • 9.For a recent review on the asymmetric reduction of ketones with biocatalysts: Nakamura K, Yamanaka R, Matsuda T, Harada T. Tetrahedron: Asymmetry. 2003;14:2659. Podea PV, Paizs C, Toşa MI, Irimie FD. Tetrahedron: Asymmetry. 2008;19:1959. McCubbin JA, Maddess ML, Lautens M. Synlett. 2008:289. Träff A, Bogár K, Warner M, Bäckvall J-A. Org. Lett. 2008;10:4807. doi: 10.1021/ol801749z.
  • 10.(a) Hamada T, Torii T, Izawa K, Noyori R, Ikariya T. Org. Lett. 2002;4:4373. doi: 10.1021/ol020213o. [DOI] [PubMed] [Google Scholar]; (b) Ma Y, Liu H, Chen L, Cui X, Zhu J, Deng J. Org. Lett. 2003;5:4373. doi: 10.1021/ol0345125. [DOI] [PubMed] [Google Scholar]; (c) Lee D-M, Kwak SH, Lee K-I. Bull. Korea Chem. Soc. 2009;30:1317. [Google Scholar]; (d) Haak RM, Berthiol F, Jerphagnon T, Gayet AJA, Tarabiono C, Postema CP, Ritleng V, Pfeffer M, Janssen DB, Minnaard AJ, Feringa BL, de Vries JG. J. Am. Chem. Soc. 2008;130:13508. doi: 10.1021/ja805128x. [DOI] [PubMed] [Google Scholar]; (e) Noyori R, Tomino I, Yamada M, Nishizawa M. J. Am. Chem. Soc. 1984;106:6717. [Google Scholar]; (f) Fei Wang, Hui Liu, Cun L, Zhu J, Deng J, Jiang Y. J. Org. Chem. 2005;70:9424. doi: 10.1021/jo0514826. [DOI] [PubMed] [Google Scholar]
  • 11.(a) Cordes DB, Kwong TJ, Morgan KA, Singaram B. Tetrahedron Lett. 2006;47:349. [Google Scholar]; (b) Hett R, Fang QK, Gao Y, Wald SA, Senanayake CH. Org. Process Res. Dev. 1998;2:96. [Google Scholar]; (c) Wilkinson HS, Tanoury GJ, Wald SA, Senanayake CH. Org. Process Res. Dev. 2002;6:146. [Google Scholar]; (d) Hett R, Senanayake CH, Wald SA. Tetrahedron Lett. 1998;39:1705. [Google Scholar]; (e) Lapis AAM, de Fátima Â, Martins JED, Costa VEU, Pilli RA. Tetrahedron Lett. 2005;46:495. [Google Scholar]; (f) Cho BT, Yang WK, Choi OK. J. Chem. Soc., Perkin Trans 1. 2001:1204. [Google Scholar]; (g) Chung JYL, Cvetovich R, Amato J, McWilliams JC, Reamer R, DiMichel L. J. Org. Chem. 2005;70:3592. doi: 10.1021/jo050178+. [DOI] [PubMed] [Google Scholar]
  • 12.(a) Itsuno S, Ito K. J. Org. Chem. 1984;49:555. [Google Scholar]; (b) Corey EJ, Shibata S, Bakshi RK. J. Org. Chem. 1988;53:2861. [Google Scholar]; (c) Choi OK, Cho BT. Tetrahedron: Asymmetry. 2001;12:903. [Google Scholar]; (d) Cho BT. Chem. Soc. Rev. 2009:443. doi: 10.1039/b811341f. and references cited therein. [DOI] [PubMed] [Google Scholar]; (e) Cho BT. Tetrahedron. 2006;62:7621. and references cited therein. [Google Scholar]; (f) Glushkov VA, Tolstikov AG. Russ. Chem. Rev. 2004;73:581. and references cited therein. [Google Scholar]; (g) Corey EJ, Helal CJ. Angew. Chem. Int. Ed. 1998;37:1986. doi: 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO;2-Z. and references cited therein. [DOI] [PubMed] [Google Scholar]; (h) Corey EJ, Bakshi RK, Shibata S. J. Am. Chem. Soc. 1987;109:5551. [Google Scholar]
  • 13.(a) Lang A, Noth H, Schmidt M. Chem. Ber. 1997;130:241. [Google Scholar]; (b) Tlahuext H, Santiesteban F, García-Báez E, Contreras R. Tetrahedron: Asymmetry. 1994;5:1579. [Google Scholar]; (c) Santiesteban F, Mancilla T, Klaébe A, Contreras R. Tetrahedron Lett. 1983;24:759. [Google Scholar]; (d) Mathre DJ, Thompson AS, Douglas AW, Carroll JD, Corley EG, Grabowski EJJ. J. Org. Chem. 1993;58:2880. [Google Scholar]; (e) Brown JM, Guy C, Lloyd-Jones GC, Layzell TP. Tetrahedron: Asymmetry. 1993;4:2151. [Google Scholar]; (f) Stepanenko V, Ortiz-Marciales M, Barnes CE, Garcia C. Tetrahedron Lett. 2006;47:7603. doi: 10.1016/j.tetlet.2008.12.061. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Ortiz-Marciales M, De Jesús M, Gonzales E, Raptis RG, Baran P. Acta Crystall. 2004;C60:173. doi: 10.1107/S0108270104000666. [DOI] [PMC free article] [PubMed] [Google Scholar]; h) Masui MST. Synlett. 1997:273. [Google Scholar]
  • 14.Stepanenko V, Ortiz-Marciales M, Barnes CL, Garcia C. Tetrahedron Lett. 2009;50:995. doi: 10.1016/j.tetlet.2008.12.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.(a) Stepanenko V, Ortiz-Marciales M, Correa W, De Jesús M, Espinosa S, Ortiz L. Tetrahedron: Asymmetry. 2006;17:112. [Google Scholar]; (b) Ortiz-Marciales M, Stepanenko V, Correa W, De Jesús M, Espinosa S. Application 11/512,599. U.S. Patent. 2006 30 August;; (c) Stepanenko V, De Jesús M, Correa W, Vázquez C, Guzmán I, Vázquez C, De la Cruz W, Ortiz-Marciales M, Barnes CL. Tetrahedron Lett. 2007;48:5799. doi: 10.1016/j.tetlet.2007.06.086. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Stepanenko V, Ortiz-Marciales M, De Jesús M, Correa W, Vázquez C, Ortiz L, Guzmán I, De la Cruz W. Tetrahedron: Asymmetry. 2007;18:2738. doi: 10.1016/j.tetasy.2007.10.044. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Stepanenko V, De Jesús M, Correa W, Bermúdez L, Vázquez C, Guzmán I, Ortiz-Marciales M. Tetrahedron: Asymmetry. 2009;20:2659. doi: 10.1016/j.tetasy.2009.11.009. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Huang K, Ortiz-Marciales M, Correa W, López XY, Pomales E. J. Org. Chem. 2009;74:4195. doi: 10.1021/jo900666r. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Stepanenko V, Huang K, Ortiz-Marciales M. Org. Synth. 2010;87:26. [PMC free article] [PubMed] [Google Scholar]; (h) Huang K, Ortiz-Marciales M. Org. Synth. 2010;87:36. and references cited therein. [PMC free article] [PubMed] [Google Scholar]
  • 16.(a) Schaus S, Brandes BD, Larrow JF, Tokunaga M, Hansen KB, Gould AE, Furrow ME, Jacobsen EN. J. Am. Chem. Soc. 2002;124:1307. doi: 10.1021/ja016737l. [DOI] [PubMed] [Google Scholar]; (b) Ready JM, Jocobsen EN. J. Am. Chem. Soc. 1999;121:6086. [Google Scholar]
  • 17. Franchini C, Carocci A, Catalano AA, Cavalluzzi MM, Corbo F, Lentini G, Scilimati A, Scilimati A, Tortorella P, Camerino DC, Luca A. J. Med. Chem. 2003;46:5238–5248. doi: 10.1021/jm030865y. Wright JT, Gregory TF, Heffner TG, Mackenie RG, Pugsley TA, Meulen SV, Wise LD. Bioorg. Med. Chem. Lett. 1997:1377. Baker NR, Byrne NR, Byrne NG, Economide AP, Javeld T. Chem. Phar. Bull. 1995:1045. doi: 10.1248/cpb.43.1045. Kirkup MP, Rizvi R, Shankar BB, Duggar S, Clader J, McCombie SW, Lin S, Yumibe N, Huie K, Heek M, Compton DS, Davis HR, Mcphail AT. Bioorg. Med. Chem. Lett. 1996:2069. (e) For an extensive review on the enantioselective ring opening of epoxides: Schneider C. Synthesis. 2006:3919.
  • 18.(a) Fan RH, Hou XL. J. Org. Chem. 2003;68:726. doi: 10.1021/jo025983s. [DOI] [PubMed] [Google Scholar]; (b) Chem J, Shum W. Tetrahedron Lett. 1995;36:2379. [Google Scholar]; (c) Surendra K, Krishnaveni SS, Nageswar YVD, Rao KR. J. Org. Chem. 2003;68:4994–4995. doi: 10.1021/jo034194n. [DOI] [PubMed] [Google Scholar]; (d) Kornblum N, Lurie AP. J. Am. Chem. Soc. 1959;81:2705. [Google Scholar]; (e) Narender M, Reddy MS, Nageswar YVD, Rao KR. Helvetica Chem. Acta. 2007;90:1107. [Google Scholar]
  • 19.Huang K, Ortiz-Marciales M, Stepanenko V, De Jesús M, Correa W. J. Org. Chem. 2008;73:6928. doi: 10.1021/jo801181d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.(a) Wang Z, Cui Y-T, Xu Z-B, Qu J. J. Org. Chem. 2008;73:2270. doi: 10.1021/jo702401t. [DOI] [PubMed] [Google Scholar]; (b) Kiasat AR, Badri R, Zargar B, Sayyahi S. J. Org. Chem. 2008;73:8382. doi: 10.1021/jo801356y. [DOI] [PubMed] [Google Scholar]
  • 21.(a) Ager DJ, Prakash I, Schaad DR. Chem. Rev. 1996;96:835–876. doi: 10.1021/cr9500038. [DOI] [PubMed] [Google Scholar]; (b) Lutz F, Lgarashi T, Kinoshita T, Asahina M, Tsukiyama K, Kawasaki T, Soai K. J. Am. Chem. Soc. 2008;130:2956. doi: 10.1021/ja077156k. [DOI] [PubMed] [Google Scholar]
  • 22.(a) Togni A, Venanzi LM. Angew. Chem., Int. Ed. Engl. 1994;33:497. [Google Scholar]; (b) Deloux L, Srebnik M. Chem. Rev. 1993;93:763. [Google Scholar]; (c) Wallbaum S, Martens J. Tetrahedron: Asymmetry. 1992;3:1475. [Google Scholar]
  • 23.(a) Sletten EM, Bertozzi CR. Angew. Chem. Int. Ed. 2009;48:6974. doi: 10.1002/anie.200900942. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Best MD. Biochemistry. 2009;48:6571. doi: 10.1021/bi9007726. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001
2_si_002

RESOURCES